CHALASANI HOSPITALS PRIVATE LIMITED

CIN: U85110AP2010pTC068262
Registered office: #50-53-14, Gurudwara Lane, Seethammadhara, Visakhapatnam -
530013, Andhra pradesh, lndia
Ph. Nor0891-2535063 Email ID: chalasanihosp@gmail.com

NOTICE OF ANNUAL GENERAL MEETING

Notice is he reby given that rhe 126 Annual General Meeting of the GHALIISANI HosplrAls
PRIVATE LI MITED will be held on Friday, the 30o day of Septe mber,2022 at 11:30 A.M.
atthe
Registered Office of th e'Company situated at 50-53-14, Gurudwara Lane, Seethammadhara,
Visakhapatnam - 5300 13, Andhra Pradesh, India to transact the followi ng business:

ORDINARY BUSINESS:

7 To receive, consider and adopt the Audited Financial statements consisting ofthe profit
& Loss Account and cash Flow Statement for the period ending 31st March, 2022 and the
Balance Sheet as on that date, Schedules and Notes together with the Directors, Report
and Independent Auditors' Report thereon.

Regd. 0ffice: By Order ofthe Board

50-53-14, for CHALISANI HOSPITALS pRrvATE LIMITED
Gurudwara Lane,
Seethammadhara, .-'P"' /'.-r-'c-t L
'\l^l'
Visakhapatnam - 530013, "
Dr.Chalasani Viiayalakshmi
Andhra Pradesh, India. Director
DIN:02944565
Place : Visakhapatnam
Date :05.09.20222.

Ptr
Crlsi-
2B50ES
Notes:

1. A Member entitled to attend and vote at the Meeting is entitles to appoint a proxy to
attend and to vote on a poll, instead of herself/ himself and the prory need not be a
Member of the company. The instrument appointing a proxy in Form MGT-11 should
be deposited at the Registered Office ofthe company not less than 4g hours before the
commencement of the Meeting.

2. Proxies submitted on behalf of the companies, societies and other

Juristic persons
must be supported by an appropriate Resolution/ Authority as applicable. A person
can act as Proxy on behalf of Members not exceeding Fifty (50) and holding in the
aggregate not more than 10% ofthe total share capital ofthe company. In case a proxy
is proposed to be appointed by a Member holding more than 10% of the total share
capital ofthe company carrying voting rightq then such prory shalr not act as a proxy
for any other Person or Shareholder.

3. corporate Members are requested to send a duly certified copy of the Board Resolution
authorizing their representatives to attend and vote at the Meeting.

4. Members or Prory should fill in the attendance slip for attending the Meeting.

5. In the case of the Joint-holders attending the Meeting. only such

Joint-holders who are
higher in the order of names will be entitled to vote.

6. The required statutory Registers and documents as prescpibed under the companies
Act, 201.3 are available for inspection at the Registered office of the company during
business hours between 9.00 A.M. to 06.00 p.M. except on holidays and will be made
available at the venue ofthe Meeting.

7. Members desiring to seek any information on the Annual Accounts are requested to
write to the company at least 7 (seven) days in advance of the Meeting so that the
information can be made available at the Meeting.

8. Members are requested to inform immediately, of any change in their address

registered with the Company quoting their Share Ledger Folio No. [s).

€ lr
\
 Form No. MGT - 11
ProryForm

[Pursuant to section 105(6) ofthe companies Act, 2013 and rule 19[3) ofthe companies
(Management and Administration) Rules, 20141

CIN u851 10AP2010PTC068262

Name ofthe Company CHAUISANI HOSPITALS PRIVATE LIMITED
Registered Office #50-53- 14, Gurudwara Lane, Seethammadhara,
Visakhapatnam - 530013, Andhra Pradesh, India

Name of the Member(s)

Registered Address

E-mail Id Folio No /Client ID DP ID

I/We, being the member(s) of ares ofthe above named Company, hereby appoint

Name: E-mail Id:

Address:

Signature, or failing him

Name: E-mail Id:

Address:

Signature , or failing him

as my/ our proxy to attend and vote (on a poll) for me/ us and on my/ our behalf at the 12e
Annual General Meeting of the CHAUISANI HOSPITALS PRMTE LIMITED to be held on
Friday, the 30d day of September, 2022 at 17:30 A.M. at the Registered Office of the Company
situated at 50-53-.14, Gurudwara Lane, Seethammadhara, Visakhapatnam - 530013, Andhra
Pradesh, India and at any adjourned thereof in respect of such resolutions as are indicated
below

Ptt

E
.t
Resolution No:

ORDINARY BUSINESS:

I To receive, consider and adopt the Audited Financial statements consisting

ofthe profit
& Loss Account and cash Flow statement for the period ending 31st Maich,2022 and,
the Balance Sheet as on that date, Schedules and Notes together with the Directors,
Report and Independent Auditors' Report thereon.

* Signed this -------- ---------,2022

day of
Affix
Revenue
Stamps

Siinature ofSharefrolder Signature of proxy holder

Signature ofthe
shareholder
across Revenue Stamp
Note:

1) This form of proiy in order to be effective should be duly completed and deposited at
the Registered 0ffice ofthe company not less than 4g hours before the co.min.emert
ofthe Meeting.
2) The proxy need not be a member ofthe Company

-'.*-!(

.r. r*,|'fL
.:, mJa,*r hjr
' i,'-,iJ...r.ar.'i' a'
 ATTENDANCE SLIP

(To be handed over at the entrance ofthe meeting hall)

12th Anntal General Meeting on the 30rh day of September. 2022at 11:30 A.M.

Full name of the members attending

(ln block capitals)
Ledger Folio No/Client ID No No. ofshares held:
Name of Proxy _
(To be filled in, ifthe proxy attends instead ofthe memberJ

I hereby record my presence at the 12th Annual General Meeting of the CHALASANI
H0SPITALS PRIVATE LIMITED to be held on Friday, the 30tr, day of Septembe r, z0zz
at 17:30
A.M. at the Registered office of the company situated at 50-53-14, Gurudwara
Lane,
Seethammadhara, Visakhapatnam - 530013, Andhra pradesh, India I

(Member's /Proxy's Signature)

Note:

1. Members are requested to bring their copies ofthe Annual Report to the Meeting.

1. Only Member/Prory holder can attend the Meeting.

2. Authorized Representatives of corporate Member(s) shal produce proper
authorization issued in their favour.
 ROUT MAP

o
@',.
n
rD EEE
o
o o
t_)
Bqq Fi,.rc. L,mr.dO
o @

o
^fun|'spon9
.*L @rn au"r

":4:tff"3:ll'#;:"' o *s ",n..
Gl

Mqn'ng$s.r,6€lEO ":*ou,

f sEldh Rdd.rE,
e
,:
.'Go sl€
!+38.9t(or.'r
(r) A --ar
^

P1t
61-
2s50B
 CHALASANI HOSPITALS PRIVATE LIMITED
' CIN: U8511OAP2010PTCO6BZ6Z
Registered office: #50-53-14, Gurudwara Lane, Seethammadhara, Visakhapatnam -
530013, Andhra pradesh, India
Ph. No:0891-2535063 Email ID: chalasanihosp@gmail.com

DIRECTORS'REPORT

lo
The Members
Chalasani Hospitals Private Limited
Visakhapatnam.

Your Directors have pleasure in presenting the 12o Annual Report and the Audited
Financial
Statements of the Company for the financial year ended 31st Marc h, ZOZZ.

1. FINANCIALS, PERFORMANCE AND STATE OF AFFAIRS OF THE COMPANY

The company's financial performance for the year under review along with previous
year's figures is given hereunder:
Ru ees in Lakhs
Particulars Year ended Year
31.03.2022 ended
31.03.2021
Revenue from operations 7233.00 6,878.87

Other Income 46.13 95.55

Total lncome 7279.73 6,9L4.52
Expenditure 6337.26 6,372.58
Profit before Depreciation 94,..87 s41.94
Less: Depreciation 407.64 4,65.09
Profit Before Tax 534.22 76.85
Less: Provision for Tax 145.41 47.28
Net Profit / Loss after the Tax 388.81 29.57

2. REVIEWOFOPERATIONS@upeesinLakhs);

During the year under report, the Company has earned an income of Rs. 7279.13 as
compared to previous year's income of Rs. 6,9t4.52 and incurred an expenditure of Rs.
6337,26 as against previous year's expenditure of Rs, 6,372.58 The provisions for
Deprecation and lncome Tax (including Deferred Tax) provided during the year were
Rs.407.64 and Rs 145,41 respectively as compared to previous year's amounts of Rs.
465,09 and provision for Tax Rs. 47,28 respectively, Hence, during the year the
company has earned a Net profit of Rs. 388.81 as compared to the previous year Net
profit of Rs. 29.5i.

Ptr
0r
il060b3
 The Board has taken steps for effective plannin& monitoring the policies and various
possible measures to control overheads and to earn profib in the coming years.
Further, the Board has also taken the required steps to extend the medical services to
some other potential places.

3. OUTLOOK&SCENARIO:

* For over 28 years of Queen's NRI Hospital has been serving the residents of Uttar
Andhra, partly Odissa and chattishghar with passion, commitment and dedication.
with NABH Accredation; keep on updating latest medical equipment as per the
' requiremenL The company offer personalized patient-centric tEeatment and care
with a comprehensive array of services and z4/l support and continuously endeavor
to uphold high ethical standards while striving to improve the quality of healthcare
delivery. Accordingly, today, the hospital is the choice for our community today.

Mission

a. To provide the most comprehensive healthcare services in a patient centric

manner
b' To continually evaluate, innovate and strive towards excellence in patient care,
research and training
c' To emphasize compassion, maintain the highest level of integrity and continue to
utilize all of our resources solely for betterment ofthe institution.
d. we constantly endeavor to provide our employees with a stimulating yet secure
w0rking environment where their individual talents are embraced and nurtured.

Vision

To be internationally recognized as an institute that provides qualitatively exceptional

yet affordable healthcare by 2030.

Values

Commitment: To our mission and our values

Integrity: To provide service in an ethical manner

Respect: For our patients and employees

Transparency: In our policies and management

Ph
F1-
2R6&
 (v) Achievements during Financial Year: ZOZI-ZT

F We have also organized 50 CME's (Continuous Medical Education) programs, 75 free

medical camps and 50 health awareness talks at different places as a part ofbusiness
development and corporate social responsibility
F Up gradation of Executive rooms on 1st floor & New Excellance OpD Chambers.

a. A New unit started in the town of Jagadalpur, chattisgarh state & cheepurupalli
Vizianagaram.

4, EXTRACTOFTHEANNUALRETURN:

As required, pursuant to Section 92(3)ofthe companies Act, 2013 and Rule 1z(l] ofthe
companies (Management and Administration) Rules, 2014, an extract ofAnnual Return
in form MGT 9 as a part ofthis Annual Report is enclosed as ANNEXURE,

5.' NUMBER OF BOARD MEETINGS CONDUCTED DURING THE YEAR UNDER REVIEW:

a) The Company has complied with the procedures relating to the Board Meetings.

b) The meetings are usually held at the Registered Office ofthe Company.

c) Draft Minutes are circulated to the Members ofthe Board for their comments and are
duly recorded in the concerned books.

MEETINGS OF THE BOARD OF DIRECTORS:

a During FinancialY ear 202L-22,05 (Five 0nly) Board Meetings were held.

b. The Dates of the Board Meetings are: !6.06.202!, 17.08.2021, O4.l 12021,
I 8.0 I .2022 and 24.02.2022.

c. The details of Directors, their attendance at Board Meetings and at the previous
Annual General Meeting ofthe Company are, given bdlow:

S Name of Director Category Board Whether present at

No. Meetings previous AGM held on
Attended 30.11.2021 and
Adiourned AGM held
on19.01.2022
1 Chalasani Director 5 Yes
Vijayalakshmi
2 Chalasani Saileesh Director 5 Yes

Ph
mp, a

h666 :i
ir
6. CONSTITUTION OF THE BOARD OF DIRECTORS:

BOARD OF DIRECTORS:

The Board of Directors ofyour company consists ofDr chalasani vijaya Lakshmi and Dr
chalasani Saileesh. There is no change in directors of company during the financial
year.

INDEPENDENT DIRECTORS:

Being a Private Limited Company, the provisions relating to appointment of

Independent Director are not applicable under section 149(6J of companies Act, zoTz
and Companies Appointment and Qualification of Directors) Rules, 2014.

KEY MANAGERIAL PERSONNEL:

The provisions relating to appointment of Key Managerial personnel under Section 203
of the companies Act, 2013 and companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014 are not applicable to the Company.

RETIREMENT BY ROTATION:

Being a Private Limited company, the provisions relating to appointment of Directors

by Retirement by Roadon are not applicable as per the provisions of Companies Act,
2073.

7, FORJT{AL ANNUAL EVALUATION:

Since the Company is neither a Listed Company nor a Public Company, the provisions of
Clause (p) to Sub-section (3) of Section 134 of the Companies Act, 2013 regarding a
statement relating to the Formal Annual Evaluation by the Board ofits own performance
and that of its Committees and individuat Directors are not applicable.

8. DIR-ECTORSRESPONSIBILITYSTATEMENT:

In accordance with the provisions of Section 134(5) of the Companies Act, 2013 the
Board hereby submits its Responsibility Statement:-

(a) in the preparation ofthe Annual Accounts, the applipable Accounting Standards
had been followed along with proper explanation relating to material
departures;

(b) the Directors had selected such Accounting Policies and applied them
consistently and made ,udgments and estimates that are reasonable and prudent
so as to give a true and fair view of the state of affairs of the Company at the end
ofthe Financial Year and ofthe profit and loss ofthe Company for that period;
 (c) The Directors had taken proper and sumcient care for the maintenance of
adequate Accounting Records in accordance with the provisions of this Act for
safeguarding the assets ofthe Company and for preventing and detecting fraud
and other irregularities;

(d) The Directors had prepared the Annual Accounts on a Going Concern basis; and

(el The Directors had devised proper systems to ensure compliance with the
provisions of all applicable laws and that such systems were adequate and
operating effectively.

9,. EXPI,/TNATION OR COMMENTS ON QUALIFICATIONS, RESERVATIONS OR ADVERSE

REMARKS OR DISCIIIIMERS MADE BY THE AUDITORS IN THEIR REPORTS UNDER
suB-sEcTroN 3(0(i) oF sEcTroN 134 OF THE COMPANIES ACT'2O13:

The Auditors' Report is self-Explanatory and does not require any comments from the
Board of Director.

10. PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS MADE UNDER SECTION

186 OF THE COMPANIES ACT, 2013:

As required under clause (g) to sub-section (3) of section 134 of the companies Act,
2013, the company has not given any Loans/ Guarantees during the year under section
186 ofthe companies Act,2013 except the existing investments which are within the
limits specified.

11. PARTICUUTRS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES

REFERRED TO IN SUB-SECTTON (1) OF SECTTON 188 rN THE PRESCRTBED FORI!:

The company has not entered into transactions which attracts the provisions ofsection
(1) of Section 188 ofthe Companies Act, 2013 except those transactions entered into in
the ordinary course ofbusiness which are disclosed in the financial statements.

12. STATE OF COMPANY',S AFFATRS UNDER SUB-SECTTON 3(i) OF SECTION 134 OF THE
COMPANIES ACT'ZOI3:

A) BRIEF DESCRIPTION OF THE COMPANY WORXING DURING THE YEAR AND

PR"ESENT STATE OF COMPANY'S AFFAIRS:

Running the Multi-Specialty Hospital and providing health care services. Though the
income rwas increased than the previous year, the company ciuldn't eam more
profits than the previous year. Now, the Board has conceived plans to improve the
operations ofthe company and is hopeful to earn profit in coming years.

Ph
BT
2860b8
 B) CHANGE IN THE NATURE OF BUSINESS, IF ANY:

There are no changes in the nature ofbusiness ofthe company during the Financial
Year 202t-22.

13, THE AMOUNTS, IF ANY, WHICH IT PROPOSES TO, CARRY TO ANY RESERVES
UNDER SUB-SECTTON 30) oF sEcTroN 134 OF COMPANTES ACT,2013:

No specific reserve is considered necessary except proposed transfer of the profit to

General Reserve as mentioned in the Financial Statements.

14. DIVIDEND:

The Board has not recommended any dividend on Equity Shares ofthe company for the
Financial Y ear 2027-22

15. MATERIAL CHANGES AND COMMITMENTS IF ANY AFFECTING THE FINANCIAL

POSITION OF THE COMPANY OCCURR,ED BETWEEN THE END OF THE FINANCIAL
YEAR TO WHICH THIS FINANCIAL STATEMENTS RELATE AND THE DATE OF THE
REPORT:

No material changes and commitments affecHng the financial position ofthe company
occurred between the end of the Financial year to which this Financial statements
relate on the date ofthis Report.

16. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION IN SUCH MANNER AS

MAY BE PRESCRIBED UNDER SUB-SECTION 3(m) OF SECTTON 134 OF COMPANIES
ACT,2013r

The particulars as prescribed under Section 13a (3)(m) of the Companies Act, 2013
read with Companies (Accounts) Rules, 2014 regardini Conservation of Energy,
Technologr Absorption are provided as under:

CONSERVATION OF ENERGY. TECHNOLOGY ABSORPTION

1. The Company has access and implemented regarding conservation of enerry and
technolory absorption wherever applicable.

2. Your Directors have been constantly endeavoring towards conservation of power

and other rare resources and also have good access to latest and advanced
technologies.

Ph
eo1
 17, FOREIGN EXCHANGE EARNINGS AND OUTGO, IN SUCH MANNER AS MAY BE
PRESCRIBED UNDER SUB-SECTIoN 3(m) oF SECTTON 134 OF COMPANIES ACT,
2O13t

FOREIGN EXCHANGE EARNINGS /OUTGO

In accordance with the provisions of 13a (3J(m) ofthe companies Act, 2013 read with
Companies' (Accounts) Rules, 2014, the information relaHng to Foreign Exchange
Earnings and 0utgo is provided as under:

Particulars 202L-22 2020-21

Rs. Rs.
Foreign Exchange Earnings NIL NIL
Foreign Exchange Outgo NIL NIL

18. DISCLOSURES:

1. The company has noted the related disclosures relating to the affairs ofthe company
from time to time and also maintained the related Registers.
2' There were no strictures or penalties imposed by the concerned Authorities relating
to the affairs ofthe Company.

3. The Company'has complied with all applicable Accounting Standards in preparation

of its financial statements.

19. DETAILS OF SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGUL/TTORS

OR COURTS OR TRIBUNALS IMPACTING THE GOING CONCERN STATUS AND
COMPANY'S OPERATIONS IN FUTURE:

There are no significant and material Orders passed by the Regulators or Courts or
Tribunals impacting the Going Concern status and Company's operatigns in future.

20, EMPLOYEERELATIONS:

The Company has recruited required personnel including Doctors, Nurses, Technicians
and professionals. Employee relations are cordial at all levels. Further, the Company
has been in touch relating to recruitment of required doctors, specialists and other
personnel from time to time as per the requirements of the Hospital.

2I, DEPOSITS:

The Company has not accepted any deposits within the meaning of Section 73 of the
Companies Act, 2013 read with the Companies (Acceptance ofDeposits) Rules, 2014.

22, CREDIT FACILITIES & GUARANTEE FACILITIES:

Ptr
fipl-
2S60bB
 The company has been availing credit & Guarantee Facilities from various Banks to
meet the business requirements from time to time.

23, INSURANCE:

All the assets ofthe company wherever necessary and to the extent required have been
adequately insured.

24, STATUTORYAUDITORS:.

At the Annual General Meeting held on 31.12.20 20, ttl/s nio a sHyeu, CHARTERED
ACCoUNTANTS, VISAKHAPATNAM (FRN: oo6186s), were appointed as staturory
Auditors of the company to hold office for 5 years till the conciusion of the Annuil
General Meering to be held in the calendar year 2025. As, ratification ofappointment of
Auditors at every Annual General lt4eeting is done away with vide notificadon dated May
7, 2018 issued by MCA, no resolution is proposed for ratification of appointment oi
Auditors.

M/s.RAO & SHYAM, CHARTERED ACCOUNTANTS, VTSAKHAPATNAM (FRN:

006186s) are continuing as the statutory Auditors of the company for the finincial
year 2022-23.

25. SHARE CAPITAL:

a. AUTHORISED SHARE CAPITAL:

The present Authorised Share Capital of the Company is Rs. 5,00,00,000/- (Rupees
Five Crores Only) as on 31.03.2022.

After the closure of the financial year, the Authorized Share Capital of the Company
has been increased hom Rs. 5,00,00,000/- (Rupees Five Crores Only) to Rs.
10,00,00,000/- (Rupees Ten Crores Only) at the EGM held on 23.06.2022.

b, ISSUEDAND PAID UP CAPITAI.:

The present Issued and Paid-up Share Capital of the Company is Rs. 496,95,100/-
(Rupees Four Crores Ninety Six Lakhs Ninety Five Thousand One Hundred Only) as
on3\.032022.

During the year the Company has not issued any Equity Shares.

c. BTIY BACK OF SECURITIES:

The Company has not bought back any ofits Securities during the year under review.

qda
["].Y1i
2s$60f0

o+.t
 d. SWEAT EQUITY:

The Company has not issued any Sweat Equity Shares during the year under review,

e, BONUS SHARES:

No Bonus Shares were issued during the year under review,

f. EMPLOYEES STOCK OPTION PUIN:

The Company has not provided any Stock Option Scheme to the Employees.

g. ISSUE OF EQUITY SHARES WITH DIFFERENTIAL RIGHTS:

The Company has not issued any equity shares with differential rights during the
year.

After the closure of the financial year,89,666 Equity Shares with differential righs
were allotted on 29.08.2022..

h, PROVISION OF MONEY BY COMPANY FOR PURCHASE OF ITS OWN SHARES BY

EMPLOYEES OR BY TRUSTEES FOR THE BENEFIT OF EMPLOYEES:

The Company has not provided any money for purchase of own Shares by Employees
or by Trustees for the benefits of Employees.

26. SUBSIDIARIES, JOIN VENTUR"ES AND ASSOCIATE COMPANIES:

The Company do'es not have Holding or Associate Company; but having a subsidiary
Company and the particulars as follows:

S. o. Name of the Company Holding/ o/o of Applicable

CIN/G]N Subsidiary/ Shares Section
Associate held
1 Vijayanagar Hospitals Subsidiary 7 4.82o/o Section 2(87)
Private Limited ofthe
u7 4L20 AP20L5PT C097 97 6 ' Companies
Act,2013

Pt

#e
27, PARTICUUTRSOFEMPLOYEES:

The particulars ofthe Employees who are covered by the provisions contained in Rule
5(2) and rule 5(3) of companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014 are:

aJ Employed throughout the year -Nil-

b) Employed for part of the year -Nil-

28, INTERNALCONTROLSYSTEM:

The company is constantly endeavoring to improve the standards ofinternal controls

in
various areirs. The existing set up ofthe internal control system is commensurate with
the size ofthe operations & nature ofits business of the Company.

29. TRANSFER OF UNCLAJMED DIVIDEND / AMOUNTS TO INVESTOR EDUCATION AND

PROTECTION FUND:

Your company did not have any funds lying unpaid or unclaimed for a period of seven
years. Therefore, there were no funds which were required to be transferred to Investor
Education and Protection Fund (lEPFJ.

30, INDICATING DE"YELOPMENT AND IMPLEMENTATION OF RISK MANAGEMENT

POLICY FOR THE CoMPANY AS REQUIRED UNDER CLTUSE
(n) TO SUB-SECTION (3)
ofSECTION 134:

The Company does not have any Risk Management poliry as thq elements of risk
threatening the Company's existence are very minimal and except competition from
other hospitals. However, all the risks are discussed in the Board meeting whenever
required and care being taking by the board.

31. DISCOLOSURE UNDER SEXUAL HARASSMENT OF WOMEN AT WORIGLACE

(PREVENTION, PROHIBITION & REDRESSAL) ACT, 2O1,3"

1 The Company has always believed in providing a safe and harassment free
wor@lace for every individual working in premises and always endeavors to
create and provide an environment that is free from discrimination and
harassment including sexual harassment.

2 During the year ended 31 March, 2022, the Company has not received any
complaint pertaining to sexual harassment.

Ph
El-
,85ffi
32. DETAILS OF POLICY DEVELOPED AND IMPLEMENTED BY THE COMPANY ON ITS
CORPORATE SOCTAI RESPONSIBILITY INITIATIVES TAKEN DURING THE YEAR
UND-ER CLAUSE (o) TO SUB-SECTIoN (3) oF SECTIoN 134 oF coMPANIEs
AcT,
2013:

The provisions of section 135 of the companies Act, 2073 read with the companies
(corporate Social,Responsibiliry poliry) Rules, 2014, are not applicable to the company.

33. NOMINATION & REMUNERATION COMMITTEE:

Nomination & Remuneration committee pursuant to Section 17g Rule 6 of chapter XIt
is not applicable.

34. STAKEHOLDERSRELATIONCOMMITTEE:

stakeholders Relation committee pursuant to section 179(5) Rule 6 of chapter xll is

not applicable.
:

35. AUDIT COMMITTEE:

Audit committee Pursuant to section 177 Rule6 of chapt€f XII of the companies Act,
2013 is not applicable.

36, VIGILMECHANISMPOLICY:

The provisions ofSection 177 ofthe Companies Act, 2013 read with Rule 6 and 7 ofthe
Companies (Meetings of the Board and its Powers) Rules, 2013 is applicable to the
Company. The company has formulated the policy of Vigil Mechanism policy for
Directors and Employees to report genuine concerns.

37. SECRETARIALAUDITREPORT:

The provisions relating to Secretarial Audit under Section 204 of tire Companies Act,
2013 and Companies (Appointment and Remuneration of Managerial Personnel) Rules,
2014 are not applicable to the Company.

38, STATUTORYCOMPLIANCE:

The Company has complied and continues to comply with all the applicable provisions
relating to affairs ofthe company.

39. ANNUALGENERALMEETING:

The Annual General Meeting of the Company is scheduled to be held on 306 day of
September, 2022. The details ofthe Agenda and Resolutions to be passed were sent out
in the Notice given to Members.

Ph
e6fi-
ts6e
40, MAINTAINENCEOFCOSTRECORDS

The provisions of Section 148 of the companies Act, 2013 related to maintenance of
Cost Records are not applicable to the Company.

41. ACKNOWLEDGEMENTS:

Your Directors express their gratitude to the shareholders of the company for the
confidence reposed in the managemenL They wish to place on record their
appreciation of the whole-hearted assistance and co-operation received by the
Company from shareholders, bankers of the Company, Medical Equipment Suppliers,
State Government, central Government Departments & Authorities, undertakings, Local
Bodies, other Agencies, other corporate Bodies and look forward to their continued
support in future. Your Directors would also like to appreciate the sincere efforts and
services rendered by all Doctors, consultants, Nurses & related staffand also employees
of the Company, Thank to our professionals, advisors, well- wishers and persons
dealing with the company.

ror chatasani H
"'r,?r:*;:t:i:iHl
1) - l1Ur,.r-*.' lt*zl-
Dr. Chalasani Vijayalakshmi
Director
DIN:029rt4565

Place : Visakhapatnam Dr. Saileesh Chalasani

Date : 05.09.2022. Director
DIN:03168499
Ph
F1-
2G6#
 ANNEXUR,E I
Form No. MGT-9
EXTRACT OF ANNUAI RETURN
As on the Financial Year ended on 31.t March, 2022

[Pursuant to Section92(3) ofthe Componies Act,2073 and Rule 12(1) ofthe Companies (Management and
Administration) Rules, 20141

I. REGISTRATION AND OTHER DETAILS:

(D Corporate Identification Number (CIN): u85 1 10AP20 10PTC0 68262

(iD Registration Date:
(iiD Name ofthe Company:
(wl Category ofCompany:
Sub-category of Company:
( l Registered office:
(vi) Whether Listed Company:
(vii) Name, Address and Contact details
Registrar and Transfer Agent:
04.05.2010
CHALASANI HOSPITALS PRIVATE LIMITED
Company Limited by Shares
lndian Non-Government Company
# 50-53-14, Gurudwara Lane, SeethammadharaMain Road,
Visakhapatnam, Andhra Pradesh,lndia
No
of N.A.

II. PRINCIPAL BUSINESS ACTMTIES OF THE COMPANY:

All the business activities contributing 10% or more ofthe total tumover ofthe Company shall be stated:

o/o to Total
s. Name and Description of main products / services NIC Cdde ofthe
Turnover of
No. Product/ service
the Company
1 Hospitals and Healthcare Service 851 100%

III. PARTICUIIIRS OF HOLDING, SUBSIDIARY AND ASSOCI,ATE COMPANIES:

sl. Name And Address Of CIN/GLN Holding/ o/o

ofShares Applicable
No. The Company Subsidiary/ held Section
Associate

7 Viiayanagar Hospitals u7 4tz0 AP20L5PTC097 97 6 Subsidiary 74.820/o SecUon

Private Limited 2187)
Plot No 125 & 126
,Srinivasa Nagar Ring
Road, Backside Of
Varun Motors
Vizianagaram
Andhra Pradesh
535002 IN
 IV. SHARE HOU)ING PATTERN:
(Equity Share Capital Breakup as percentage of Total Equity)

(i) Category-wise Share Holding:

o/o
Category of No, ofShares held at the beginning of ofthe
No. ofShares held at the end
Shareholders the year [As on 31-March-2021] year [As on 31-M ardFz0zzl Chang
e
Dema Physical Total o/o of Demat Physical Total o/o of
during
t Total Total the
Shares Shares year
A, Promoters
[1) Indian
aJ lndividual/ 49,64,41
49,64,4t0 49,64,+10 99.90 49,6+,470 99.90
HUF 0
b) Central
Govt
cJ State
Govt[s)
d) Bodies
Corp.
e) Banks / FI
0 Any other
Total
shareholding 49,64,41
49,64,410 49,64,470 99.90 49,64,410 99.90
of Promoter 0
(A)
B.Public
Shareholding
1.
Institutions
a) Mutual
Funds
b) Banks / FI
c) Central Govt
d) State
Govt(sl
e) Venture
Capital Funds
f) Insurance
Companies
sl FIls
h) Foreign
Venture
Capital Funds
i) others
(speciff)
sub-total
(BX1):-
2. Non-
Insdtutions
a) Bodies
Corp,
il Indian
ii) overseas
-.tt . ,

rd,/
S&tr '
2iF}6Fr'q
tI
b)
Individuals
i) Individual
shareholders
holding
5,100 5,100 0.10 5,100 5,100 0.10
nominal share
capital upto
Rs. I lakh
ii) Individual
shareholders
holding
nominal share
capital in
excess of Rs 1
lakh
c) OtheE
(specify)
Non Resident
Indians
Overseas
Corporat€
Bodies
Foreign
Nationals
Clearing
Members
Trusts
Foreign
Bodies - D R
Sub-total
5,100 5,100 0.10 5,100 5,100 0.10
tB)(2):-
Total Public
Shareholding
(B)=(BX1)+
tBx2)
C. Shares held
by custodian
for GDRs &
ADRs
Grand Total 49,69,51
49,69,st0 49,69,5t0 100 49,69,51O
0
100
(A+B+C)

(ii) Shareholding of Promoter:

s.
Shareholde/ Shareholding at the beginning of Share holding at the end ofthe year
o/o
N
s Name the year change
o in
Vo of o/o of o/oof Shares share
%oofShares
total total
Pledged / Pledged / holding
No, of Shares No. of Shares
encumbered during
encumbered
Shares of the Shares ofthe to total the
to total
Compan Compan year
Shares Shares
v v
I Chalasani 49,64,470 99.900r'0 49,54,470 99.900/o
Viiaya
Lakshmi

ita/g

t
 (iii) Change in Promoters' Shareholding (please specify, ifthere is no change):

Shareholding at the Cumulative Shareholding

s.
beginning during the
No,
ofthe year year
o/o of total o/o of total
No. of No. of
shares of the shares ofthe
shares shares
company comDany
1 Chalasani Vi jayal Lakshmi
At the beginning ofthe year +9,64,410 99.90o/o 49,64,4t0 99.90%

At the end ofthe year 49,64,410 99.90Vo 49,64,+t0 99.90o/o

(iv) Share holding Pattern of top ten Shareholders:

(Other than Directors, Promoters and Holders ofGDRs and ADRs)

Shareholding at the Cumulative Shareholdlng

beginning during the
s. For Each ofthe Top 10 ofthe year year
Shareholders o/o of total
No. Yo of total
No. of No, of
shares of the shares of the
shares shares
comDanv company
I Usha Chalasani

At the beginnins ofthe year 2,550 0.050/o 2,550 0.05o/o

At the end of the year 2,550 0.05o/o 2,550 0.050/o

(v) Shareholding of Directors and Key Managerial Personnel:

Shareholding at the Cumulative Shareholding

beginning ofthe year during the vear
s. Shareholding ofeach Directorc and o/o of total %o oftotal
No, each Key Managerial Personnel No. of No. of
shares ofthe shares ofthe
shares shares
company company
1 Chalasani Vi.iaya Lakshmi
At the beginning ofthe yeal 49,64,470 99.90% 49,64,4t0 99.90Vo
At the end ofthe year 49,64,470 99.90o/o 49,64,4t0 99.90o/o
.,
Chalasani Saileesh
At the beginning of the year 2,550 0.05% 2,550 0.050/o
At t}e end ofthe year 2,550 0.05% 2,550 0.0570
V, INDEBTEDNESS:
Indebtedness of the Company including interest outstanding/accrued but not due for payment

Secured Loans
excluding
Unsecured Total
Deposits
Loans Indebtedness
deposits
lndebtedness at the beginning ofthe
financial year
i) Principal Amount 75,34,82,000.00 3,71,000.00 75,38,53,000.00
ii) Interest due but not paid
iii) Interest accrued but not due
Total (i+ii+iii) 75,34,82,000.00 3,71p00.0o 75,38,53,000.00

Change in Indebtediress during the

financial year
+ Addition

* Reduction 1,73,96,000.00 3,71,000.00 7,77 ,67 ,OO0

Net Change 1,73,96,000.00 3,71,000.00 L,77,67,OOO

Indebtedness at the end ofthe

financial year
i) Principal Amount 73,50,85,000.00 73,60,86000.00
ii) lnterest due but not paid
iii) [nterest accrued but not due
Total (i+ii+iii) 73,60,85,000.00 73,50,86,000.00

VI. REMUNERATION OF DIR.ECTORS AND XE"Y MANAGERIAL PERSONNEL:

A. Remuneration.to.Managin8 Director, Whole-time Directors and/or Manager..

s. Name of MD/$rTDl
Particulars of Remuneration Total Amount
No, Manager

1 Gross salary
(aJ Salary as per provisions contained in
section 17(1) ofthe Incoine-tax Act, 1961

@J Value of peryuisites u/s 17(2) lncome-

tax Act, 1961
(c) Profits in lieu ofsalary under section
17(3) Income- tax Act, 1961

2 Stock Option
3 Sweat Equity
4 Commission
- as % ofprolit r
- others, speciry...

5 Others, please speciff

Total (AJ
Ceiling as per the Act -N.A- .NA.

t
 B Remuneration to other DirectoN:

s.
Particulars of Remuneration Name of Directors Total Amount
No.

1 Independent Directors

Fee for attending board committee meetings

Commission .N.A-
Others, please specify
Total (1)
2 Other Non-Executive Directors
Fee for attending board committee meetings
Commission
Others, please speciff
Total (2J
Total [B)=(1+2)
Total Managerial
Remuneration
Overall Ceiling as per the Act .N.A. -NA-

C. Remuneration to Key Managerial Personnel other than MD / Manager / WTD:

s.
Particulars of Remuneration Key Managerial Personnel
No.
CEO CS CFO Total
I Gross salary
(aJ Salary as per provisions contained in section
17[1] ofthe Income-tax Act, 1961
[b) Value ofperquisites u/s 17(2) Income-tax
Act, 1961
(c) Profits in lieu of salary under section 17(3)
Income-tax Act, 1961 Not Applicable
, Stock Option
3 Sweat Equity
4 Commission
- as o/o ofprofit
others, speciry...
5 Others, please specify
Total
vll. PENAJ.TIES / PUNISHMENT/ COMPOUNDING OF OFFENCES:

Type Section of the Brief Details of Authority Appeal made,

Companies Description Penalty / IRD/ if any (give
Act Punishment/ NCLT/ Details)
Compounding couRTl
fees imposed
id COMPANY
Penalty
Punishment NIL
Compounding
B. DIRECTORS
Penalty
Punishment NIL
Compounding
C. OTHER OFFICERS IN DEFAULT
Penalty
Punishment NIL
Compounding

For Chalasani Hospitals private Limited

Uua-ro.l.'+ LL'-
,rl
(Dr. Chalasani Vijayalakhmi)
Director
DIN: 02944565

( Dr. Saileesh Chalasani )

Place r Visakhapatnam Director
Date : 05.09.2022. DIN: 03168499
ilAU ,E SmUuL,X
Chortered Accountonls

INDEPENDENT AUDITORS' REPORT

To
The Members of
Chalasani Hospitals Private Limited

Report on the audit of the Financial Statements:

Opinion
We have audited the accompanying financral statements of Chalasani Hospitals Private
Limited ("the company"), which comprise the Balance sheet as at 31.1 March 2021, the
statement of Profit and Loss, the statement of cash flows for the year then ended and notes
to financial statements, including a summary of significant accounting policies and other
explanatory information.

ln our opinion and to the best of our information and according to the explanations given to
us, the aforesaid frnancial statements give the rnformation required by the companies Act.
2013 ("the Act") rn the manner so requrred and grve a true and fair view rn coniormity with
the accounting principles generally accepted rri lndia of the state of affairs of the company
as at 3lstMarch 2021, its loss and cash flows for the year ended on that date.

Basis for Opinion

we conducted our audit in accordance with the standards on Auditing (sAs) specified under
section 143 (10) of the companies Act, 2013. our responsibilitres undii those btandards are
further described in the auditor's responsibilrties for the audit of the frnancial statements
section of our report. we are independent of the company in accordance with the code of
ethrcs issued by the lnstitute of Chartered Accountants of lndia together with the ethical
requirements that are relevant to our audit of the financial statements under the provisions
of
the companies Act, 2013 and the rules thereunder, and we have fulfiled our other ethicar
responsibilities in accordance with these requiremenls and the code of Ethics. we beheve
that the audit evidence we have obtarned is sufficient and appropriate to provide a basis for
our opinion.

lnformation other than the financiar statements and auditors' report thereon
The Company's board of directors is responsrble for the preparation of the other
tnformation.
The other information comprises the informatron lnctuded in the Board,s neport
inituoing
Annexures to Board's Report, Business Responsibirity Report
but does not inctuJe tne
financial statements and our auditor,s report thereon

our opinion on the financiar statements does not cover the other rnformation
and we do not
express any form of assurance conclusion thereon.

ln connection with our audit of the financiar statements,

our responsibirity is to read the other
tnformation and' ln doing so, consider whetner
tne otner inrormation is materially inconsistent
wrth the standarone frnancral statements or
our xnowteije
- -"- obtained during tn" oi o*
audrt or otherwise appears to be materrally
,,rstateJ. "orir"

fr
# 49-54-13t6,,Batayya Sastry Layout
VISAKHAPATNAM_53O
phone 0891-2700800
250406A Zi9o6ie,'
"' O1 3
 materially inconsistent with the standalone financial statements or our knowledge
obtained during the course of our audit or otheruise appears to be materiaily
misstated.

lf, based on the work we have performed, we conclude that there is a material
misstatement of this other information, we are required to report that fact. we have
nothing to report in this regard.

Management's Responsibility for the Financial Statements:

The company's Board of Directors are responsible for the matters stated in section
134(5) of the Companies Act, 2013 ("the Act,,) with respect to the preparation and
presentation of these financial statements that give a true and fair view of the
financial position, financlal performance and cash flows of the company in
accordance with the accounting principles generally accepted in lndia, including the
Accounting Standards specified under Section 133 of the Act. This responsibility-also
includes the maintenance of adequate accounting records in accordance wiin tne
provisions of the Act for safeguarding the assets of the company and for preventing
and detecting frauds and other irregularities; selection and application of appropriate
accounting policies; making judgments and estimates that are reasonable and
prudent; and design, implementation and maintenance of adequate internal financial
controls, that were operating effectively for ensuring the accuracy and completeness
of the accounting records, relevant to the preparation and presentation of the
financial statements that give a true and fair view and are free from material
misstatement, whether due to fraud or error.

ln preparing the financial statements, management is responsible for assessing the

company's ability to continue as a going concern, disclosing, as applicabre, ,"tt"r.
related to going concern and using the going concern baiis of accounting unless
management either intends to liquidate the company or to cease operationi, or has
no realistic alternative but to do so.

The board of directors are also responsible for overseeing the company's financial
reporting process.

Auditor's Responsibility for the audit of the financial statements:

our objectives are to obtain reasonable assurance about whether the financial
statements as a whole are free from material misstatement, whether
due to fraud or
error, and to issue an auditor's report that includes our opinion. R""sonaute
assurance is a high rever of assurance, but is not a guarantee that
an audit
conducted in accordance with sAs will always detect a material misstatement
when
it exists. Misstatements can arise from fraud or error and
are considered material if,
individually or in the aggregate, they courd reasonabry
be expected to influence the
economic decisions of users taken on the basis of theie financial
statements.
As part of an audit in accordance with SAs, we exercise professionar
judgment and
maintain professional scepticism throughout the
audit We also:
' ldentify and assess the risks of materiar misstatement
of the financiar
statements, whether due to fraud or error,
design anO perform' auOit
pro-cedures responsive to those risks,
and obtain 'audit inJi i.
sufficient and appropriate to provide r'u".i.
for our opinion."rii"n."
The risk of not
detecting a materiar misstatement resrrtinj
irom fraud is higher than for one

ok
 resulting from error, as fraud may involve collusion, forgery, intentional
omissions, misrepresentations, or the override of internal control.

Obtain an understanding of internal control relevant to the audit in order to

design audit procedures that are appropriate in the circumstances. Under
section '143(3)(i) of the Companies Act, 2013, we are also responsible for
expressing our opinion on whether the company has adequate internal
financial controls system in place and the operating effectiveness of such
controls

Evaluate theappropriateness of accounting policies used and the

reasonableness of accounting estimates and related disclosures made by
management.

Conclude on the appropriateness of management's use of the going concern

basis of accounting and, based on the audit evidence obtained, whether a
material uncertainty exists related to events or conditions that may cast
significant doubt on the Company's ability to continue as a going concern. lf
we conclude that a material uncertainty exists, we are required to draw
attention in our auditor's report to the related disclosures in the financial
statements or, if such disclosures are inadequate, to modify our opinion. Our
conclusions are based on the audit evidence obtained up to the date of our
auditor's report. However, future events or conditions may cause the
Company to cease to continue as a going concern.

Evaluate the overall presentation, structure and content of the financial

statements, including the disclosures, and whether the financial statements
represent the underlying transactions and events in a manner that achieves
fair presentation.
We communicate with those charged with governance regarding, among other
matters, the planned scope and timing of the audit and significant audit findings,
including any significant deficiencies in internal control that we identify during our
audit.

We also provide those charged with governance with a statement that we have
complied with relevant ethical requirements regarding independence, and to
communicate with them all relationships and other matters that may reasonably be
thought to bear on our independence, and where applicable, related safeguards.
From the matters communicated with those charged with governance, we determine
those matters that were of most significance in the audit of the financial statements
for the financial year ended March 31, 2022 and are therefore the key audit matters.
We describe these matters in our auditor's report unless law or regulation precludes
public disclosure about the matter or when, in extremely rare circumstances, we
determine that a matter should not be communicated in our report because the
adverse consequences of doing so would reasonably be expected to outweigh the
public interest benefits of such communication.

&
Emphasis of Matter
We draw attention to the following matter. Our opinion is not qualified in respect of
this matter.
a) Outstanding balances under Trade Payables and Trade Receivables including
disallowances by the Customers are subject to reconciliation, the impact of
which is not ascertainable.

Report on Other Legal and Regulatory Requirements:

1. As required by the Companies (Auditor's Report) Order,2016 ("the Orde/'),
issued by the Central Government of lndia in terms of sub-section (11) of section
143 of the Companies Act, 2013, we give in the Annexure "A", a statement on the
matters specified in paragraphs 3 and 4 of the Order, to the extent applicable.

2. As required by Section 143 (3) of the Act, we report that:

a) We have sought and obtained all the information and explanations which to
the best of our knowledge and belief were necessary for the purposes of our
audit.

b) ln our opinion, proper books of account as required by law have been kept by
the Company so far as it appears from our examination of those books.

c) The Balance Sheet, the Statement of Profit and Loss and the Cash Flow
Statement dealt with by this Report are in agreement with the books of
account.

d) ln our opinion, the aforesaidfinancial statements comply with the Accounting

Standards specified under Section 133 of the Act, read with rule 7 of the
Companies (Accounts) Rules, 2014.

e) On the basis of written representations received from the directors as on 31st

March 2Q22 taken on record by the Board of Directors, none of the Directors
is disqualified as on 31st March 2022, from being appointed as a director in
terms of Section 164 (2) of the Act.

0 With respect to the adequacy of the internal financial controls over financial
reporting of the Company and the operating effectiveness of such controls,
refer to our separate report in "Annexure - 8". Our report expresses an
unmodified opinion on the adequacy and operating effectiveness of the
Company's internal financial controls over financial reporting; and

g) With respect to the other matters to be included in the Auditor's Report in

accordance with Rule 11 of the Companies (Audit and Auditors) Rules, 2014,
in our opinion and to the best of our information and according to the
explanations given to us:

i. The Company does not have any pending litigations which would
impact its financial position,

fi
 . The Company did not have any longterm contracts including derivative
contracts for which there were any material foreseeable losses,

t There were no amounts which were required to be transferred to the

lnvestor Education and Protection Fund by the Company.

tv (a) The management has represented that, to the best of it's

knowledge and belief, no funds have been advanced or loaned or
invested (either from borrowed funds or share premium or any other
sources or kind of funds) by the company to or in any other person or
entity, including foreign entities ("lntermediaries"), with the
understanding, whether recorded in writing or otherwise, that the
lntermediary shall, whether, directly or indirectly lend or invest in other
persons or entities identified in any manner whatsoever by or on behalf
of the company ("Ultimate Beneficiaries") or provide any guarantee,
security or the like on behalf of the Ultimate Beneficiaries;

(b) The management has represented, that, to the best of it's

knowledge and belief, no funds have been received by the company
from any person(s) or entity(ies), including foreign entities ("Funding
Parties"), with the understanding, whether recorded in writing or
otheMise, that the company shall, whether, directly or indirectly, lend
or invest in other persons or entities identified in any manner
whatsoever by or on behalf of the Funding Party ("Ultimate
Beneficiaries") or provide any guarantee, security or the like on behalf
of the Ultimate Beneficiaries; and

(c) Based on audit procedures which we considered reasonable and

appropriate in the circumstances, nothing has come to our notice that
has caused us to believe that the representations under sub-clause (i)
and (ii) contain any material mis-statement.

The company has neither declared nor paid any dividend during the
yeat.

For
I
0
SHVAM
Chartered Accountants UDIN ) g l_o(c )? $ Bnv 7 E I r_z-r-
FRNo.0061865

$<"''*MrA^
K. Rama Koteswara Rao
Pa rtner Date: 5rh September 2022
Mem. No. 201433 Place: Visakhapatnam
Annexure- A to the lndependent Auditor's Report

(Referred to in paragraph 1 under 'Reports on Other Legal and Regulatory

Requirements' section of our report to the members of Chalasani Hospitals Private
Limited of even date)

(i) ln respect of the Company's Property, Plant and Equipment

a) The Company has maintained proper records showing full particulars,
including quantitative details and situation of Property, Plant and
Eq u ipment.

b) The company has maintained proper records showing full particulars of

intangible assets.

c) As explained to us, the Company has physically verified assets' in

accordance with a phased program of verification, which in our opinion is
reasonable, having regard to the size of the Company and nature of its
assets. According to the information and explanation given to us, no
material discrepancies were noticed on such physical verification as
compared with the available records.

d) According to the information and explanalions given to us and on the basis

of our examination of the records of the Company, the title deeds of
immovable properties owned by the company are held in the name of the
Company

e)
' According to the information and explanations given to us and on the basis
of our examination of the records of the Company, the Company has not
revalued its property, plant and equipment or lntangible assets or both
during the year.

f) According to the information and explanations given to us and on the basis

of our examination of the records of the Company, there are no
proceedings initiated or pending against the Company for holding any
benami property under the Prohibition of Benami Property Transactions
Act, 1988 and rules made thereunder.

(ii) a) Physical verification of stock of medicines, stores, spares, chemicals and

lab materials has been conducted by the Management at reasonable
intervals during the year. ln our opinion, the frequency of such verification is
reasonable. According to the information and explanations given to us and
as examined by us, no material discrepancies were noticed on physical
verification as compared to the book records.

b) According to the information and explanations given to us and on the basis

of our examination of the records of the Company, the Company has been
sanctioned working capital limits in excess of five crore rupees, in
aggregate, from banks on the basis of security of current assets. ln respect
of first 3 q uarters, the company has not passed any entry for inventory in
the books of accounts. Accordingly, the quarterly returns filed with the bank

&
 authorities for the first 3 quarters cannot be matched withed the books of
accounts. ln respect of Q4 return filed with the bank authorities, the
discrepancies are stated below.

Quarter Sanctioned Nature Nature of Amount as Amount as Differences Remarks

Amount of Discrepancies per returns/ per books
Current statements of accounts
Assets
4 53 Crores lnvento The Company 3,16,55,562 2,30,67,442 85,88,120 The
ries has valued the variance is
inventories on an on
estimated basis account ol
for submitting to different
the bank. methods
However the being
final valuation used al
has been valued the time o'l
in line with AS-2 valuation
principles. of
inventorie.

(iii) (a) The company has not provided loans or advances in the nature of loans,
or stood guarantee, or provided security to any other entity.

(b) The investments made by the company are not prejudicial to the
Company's interest. The company has not stood guarantee, provided security
to any other entity during the year.

(c) The Company has not granted loans or advances in the nature of loans
during the year. Accordingly reporting under Clause (iii)(c), (d) and (e) of the
Order is not applicable.

(iv) ln our opinion and according to information and explanation given to us, the
company has not granted any loans or provided any guarantees or given any
security to which the provision of section 185 and 186 of the Companies Act,
2013. Further, the company has complied with the provisions of Section 185
and 186 of the Companies Act, 2013 in relation to investments made.

(v) ln our opinion and according to the information and explanations given to us,
the company has not accepted any deposits and accordingly Clause 3(v) of
the order is not applicable.

(ui) The central Government of lndia has not prescribed the maintenance of cost
records under sub-section (1) of section 14g of the Act for any of the activities
of the company and accordingry paragraph 3(vi) of the order ii not applicable.

(vii) ln respect of statutory dues:

a) According to the information and expranation given to us, there was no
undisputed amounts payable in respect of provident Fund, Employees
State lnsurance, lncome Tax, Service Tax, Sales Tax, Customs 6uty,

0h
 Excise Duty, Value Added Tax, Cess and any other material statutory
dues were in arrears, as at 31st March 2022 for a period of more than six
months from the date they became payable except for the following:

Name of the Statute Nature of the Amount ln Period to which

Dues Rs. Amount relates
lncome Tax Act, 1961 lncome Tax 1001303 2014-15
lncome Tax Act,1961 lncome Tax 921841 2015-16
lncome Tax Act,1961 lncome Tax 1189314 2016-17
lncome Tax Act,1961 lncome Tax 3163679 2017-18
lncome Tax Act,1961 lncome Tax 7065922 2018-19
Total 13342059

b) According to information and explanations given to us, there are no

statutory dues that have not been deposited on account of dispute as at
31$ March2022.

(viii) According to the information and explanations given to us and on the basis of
our examination of the records of the Company, the Company has not
surrendered or disclosed any transactions, previously unrecorded as income
in the books of account, in the tax assessments under the lncome-tax Act,
1961 as income during the year.

(ix) (a) ln our opinions and according to the information and explanations given to
us, the Company has not defaulted in repayment of loans or other borrowings
or in the payment of interest thereon to any lender.

(b) ln our opinions and according to the information and explanations given to
us, the company has not been declared as willful defaulter by any bank or
financial institution or other lender.

(c) ln our opinions and according to the information and explanations given to
us, the term loans were applied for the purpose for which the loans were
obtained.

(d) ln our opinions and according to the information and explanations given to
us, the funds raised on short term basis have not been utilised for long term
purposes.

(e) ln our opinions and according to the information and explanations given to
us, we report that the Company has not taken any funds from any entity or
person on account of or to meet the obligations of its subsidiary.

(f1ln our opinions and according to the information and explanations given to
us, we report that the Company has not raised loans during the year on the
pledge of securities held in its subsidiaries.

(x) (a) The Company has not raised any money by way of initial public offer or
further public offer (inctuding debt insirumenti;. AccoiOingty, Clause 3(x)(a) of
the order is not applicable.

rt
 (b) According to the information and explanations given to us, the Company
has not made any preferential allotment or private placement of shares or fully
or partly convertible debentures during the year as per the requirements of
Section 42 and Section 62 of the Companies Act,2013.

(xi) (a) To the best of our knowledge and according to the information and
explanations given to us, no fraud by the Company has been noticed or
reported during the year that causes the financial statements to be materially
misstated.

(b) According to the information and explanations given to us, no report under
sub-section (12) of Section 143 of the Companies Act, 2013 has been filed by
the auditors in Form ADT4 as prescribed under Rule 13 of Companies (Audit
and Auditors) Rules, 2014 with the Central Government.

(c) The establishment of whistle blower mechanism is not applicable to the

Company. Accordingly, Clause 3(xi)(c) is not applicable to the Company.

(xii) The Company is not a Nidhi company. Accordingly, Clause 3(xii) of the Order
is not applicable.

(xiii) According to the information and explanations given to us and based on our
examination of the records of the Company, transactions with the related
parties are in compliance with sections 177 and 188 of the Act where
applicable and details of such transactions have been disclosed in the
financial statements as required by the applicable accounting standards.

(xiv) (a) Based on information and explanations provided to us and our audit
procedures, in our opinion, the Company has an internal audit system
commensurate with the size and nature of its business.
(b) We have considered the internal audit reports of the Company issued till
date for the period under audit.

(*") According to the information and explanations given to us and based on our
examination of the records of the Company, the Company has not entered
into noncash transactions with directors or persons connected with him as
referred to in Section 192 of the Act. Accordingly, paragraph 3(xv) of the
Order is not applicable.

(xvi) (a) According to the information and explanations given to us, the provisions
of section 45-lA of the Reserve Bank of lndia Act 1934 are not applicable to
this company.

(b) The company is not engaged in any Non-Banking Financial or Housing

Finance activities. Accordingly, the requirement to report on Clause 3(xvi)(b)
of the Order is not applicable.

(c) The company is not a Core lnvestment Company (ClC) as defined in the
regulations made by the Reserve Bank of lndia. Accordingly, the requirement
to report on Clause 3(xvi)(c) of the Order is not applicable.

0k
 (d) According to the information and explanations provided to us during the
course of audit, the Group does not have any ClC Accordingly, the
requirements of clause 3(xviXd) are not applicable.

(xvii) The Company has not incurred cash losses in the current and in the
immediately preceding financial year. Accordingly' clause 3(xvii) of the Order
is not applicable.

(xviii) There has been no resignation of the statutory auditors during the year'
Accordingly, clause 3(xviii) of the Order is not applicable.

(xix) According to the information and explanations given to us and on the basis of
the finaniial ratios, ageing and expected dates of realisation of financial
assets and payment of financial liabilities, other information accompanying the
financial statements, our knowledge of the Board of Directors and
management plans and based on our examination of the evidence supporting
the aisumptions, nothing has come to our attention, which causes us to
believe that any material uncertainty exists as on the date of the audit report
that the Company is not capable of meeting its liabilities existing at the date of
balance sheet as and when they fall due within a period of one year from the
balance sheet date. We, however, state that this is not an assurance as to the
future viability of the Company. We further state that our reporting is based on
the facts up to the date of the audit report and we neither give any guarantee
nor any assurance that all liabilities falling due within a period of one year from
the balance sheet date, will get discharged by the Company as and when they
fall due.

(xx) (a) ln our opinions and according to the information and explanations given to
us, in respect of other than ongoing projects, the company has not transferred
unspent amount to a Fund specified in Schedule Vll to the Companies Act
within a period of six months of the expiry of the financial year in compliance
with second proviso to sub-section (5) of section 135 of the said Act;

(b) ln our opinion and according to the information and explanations given to
us, any amount remaining unspent under sub-section (5) of section 135 of the
Companies Act, pursuant to any ongoing project, has not been transferred to
special account in compliance with the provision of sub-section (6) of section
135 of the said Act;

rO, BA@ E SHYANil

Chartered Accountants
FRNo.006'1865
UDIN 222ol83RtaVf6 \zl-l--

K. Rama Koteswara Rao

Partner Date: 5rh September 2022
Mem. No 201433 Place: Visakhapatnam
Annexure - B to the lndependent Auditors' Repoft
(Referred to in paragraph 2(f) under'Reports on Other Legal and Regulatory
Requirements' section of our report to the members of Chalasani Hospitals Private
Limited on the financial statements of even date)

Report on the lnternal Financial Controls with reference to financial statements

under Clause (i) of Sub-section 3 of Section 143 of the Companies Act, 2013
('the Act')
We have audited the internal financial controls over financial reporting with reference
to financial statements of Chalasani Hospitals Private Limited ('the Company') as of
March 31, 2022 in conjunction with our audit of the financial statements of the
Company for the year ended on that date.

Management's Responsibility for lnternal Financial Controls with reference to

Financial Statements
The Company's management is responsible for establishing and maintaining internal
financial controls with reference to financial statements based on the internal control
over financial reporting criteria established by the Company, considering the
essential components of internal control stated in the Guidance Note on Audit of
lnternal Financial Controls Over Financial Reporting issued by the lnstitute of
Chartered Accountants of lndia (the 'Guidance Note'). These responsibilities include
the design, implementation and maintenance of adequate internal financial controls
with reference to financial statements that were operating effectively for ensuring the
orderly and efficient conduct of its business, including adherence to Company's
policies, the safeguarding of its assets, the prevention and detection of frauds and
errors, the accuracy and completeness of the accounting records, and the timely
preparation of reliable financial information, as required under the Act.

Auditors' Responsibility
Our responsibility is to express an opinion on the Company's internal financial
controls over financial reporting with reference to financial statements based on our
audit. We conducted our audit in accordance with the Standards on Auditing
prescribed under Section 143(10) of the Act and the Guidance Note, to the extent
applicable to an audit of internal financial controls. Those Standards and the
Guidance Note require that we comply with the ethical requirements and plan and
perform the audit to obtain reasonable assurance about whether adequate internal
financial controls over financial reporting was established and maintained and if such
controls operated effectively in all material respects.

our audit involves performing procedures to obtain audit evidence about the
adequacy of the internal financial controls system over financial reporting and their
operating effectiveness.

nk
Our audit of internal financial controls over financial reporting included obtaining an
understanding of internal financial controls over financial reporting, assessing the
risk that a material weakness exists, and testing and evaluating the design and
operating effectiveness of internal control based on the assessed risk. The
procedures selected depend on the auditors' judgment, including the assessment of
the risks of material misstatement of the financial statements, whether due to fraud
or error.
We believe that the audit evidence we have obtained is sufficient and appropriate to
provide a basis for our audit opinion on the Company's internal financial controls
system over financial reporting with reference to financial statements.

Meaning of lnternal Financial Controls Over Financial Reporting

A company's internal financial control over financial reporting is a process designed
to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles. A company's internal financial control over
financial reporting with reference to financial statements includes those policies and
procedures that

(1) Pertain to the maintenance of records, that in reasonable detail, accurately

and fairly reflect the transactions and dispositions of the assets of the
company;

(2) Provide reasonable assurance that transactions are recorded as

necessary to permit preparation of financial statements in accordance with
generally accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance with
authorizations of management and directors of the company; and

(3) Provide reasonable assurance regarding prevention or timely detection of

unauthorized acquisition, use, or disposition of the company's assets that
could have a material effect on the financial statements.

lnherent Limitations of lnternal Financial Controls Over Financial Reporting

Because of the inherent limitations of internal financial controls over financial
reporting, including the possibility of collusion or improper management override of
controls, material misstatements due to error or fraud may occur and not be
detected. Also, projections of any evaluation of the internal financial controls over
financial reporting to future periods are subject to the risk that the internal financial
control over financial reporting may become inadequate because of changes in
conditions, or that the degree of compliance with the policies or procedures may
deteriorate.

ek
Opinion
ln our opinion, to the best of our information and according to explanations given to
us, the Company has, in all material respects, an adequate internal financial controls
system over financial reporting with reference to financial statements and such
internal financial controls over financial reporting were operating effectively as at 31st
March 2022, based on the internal control over financial reporting criteria established
by the Company considering the essential components of internal control stated in
the Guidance Note on Audit of lnternal Financial Controls over Financial Reporting
issued by the lnstitute of Chartered Accountants of lndia.

ro'.BAt0 E S
Chartered Accountants uDrN: 9 2.2o(q U BAftY 7e ILLL
FRNo.0061865

Rama Koteswara Rao

Partner Date: 5h September 2022
Mem. No.201433 Place: Visakhapatnam
 -r'
Chalasani Hospitals Prirlatc Limited
5ll 53 1-1, Gurrc[vara Laoe, Seethammadhara, \'isakhapatnam 530013

BAI-ANCE SHEET AS AT 31" MARCH m22 in lakhs

Notc A6 at As at
Paniculars
No 3lst M^rch 2022 31et Ma.ch 2021
I. EQUITY AND LIABILITIES
(l) Shareholder's Funde
(a) Share Capiral 1 496.95 496.95
(b) Resen cs and Surplus ,l 5r 8.96 130.15

(2) Non-Current Liabilities

(a) I-ong-rerm borowings 5 5550.49 5996 60

(3) Current Liabilities

(a) Short- term borrowings 6 1810.37 1541.93
@) Trade Payables
Total ()urstanding dues of micro enterprises and smell
7
enterprises 0.00 0.m
'Iotal ( )urstandmg dues of creditors other than
7
micro and small enterprises 1601.42 15'11.87
(c) Other Current Liabilities 8 2$.60 214.80

Total 10189.80 9952.11

II. ASSETS
(1) Noo-current assets
(a) Propertl,, Planr and Eqrupment and Intangible Assets
(i) Tangible assets 9 2594;/ 5 2661.45
(ii) Inrangrble assets 9 6.15 1.14
(iii) Cepiral !?ork in Progress 10 299.69 161.97
@) Deferred Tax -\sset 385.2'l 530.69
(c) Non curreot Investrnents 1l 318.00 318.00
(d) Long'fcrm loans and advances 12 ,153.78 .111.54

(2) Curear assets

(a) lnventories 13 230.67 180.16
(b) Trade receivables 14 4559.56 3851.29
(c) Cash aod cash equrvalenrs l5 3U.76 95'7.23
(d) Shon rcln )oans and advances t6 951.16 896.84

Toral 10189.80 9952.31

Notes ro \ccouors 1to28
The accompanying Notes are an integral part of the Fmancial Statements

As per ou-r Reporr of even date

For R-\( ) .\N D SFIY,llrI
Charrered .\ccorrotanrs For and on Lrchalf of rhe Board
'( Id,
a, v
'..,

o Ph
ill-
(-l
.\, R.\,\L\ )TES\T('-\R{ R\o
PARTI\i ER
C.\I I-\HIII
NL{NAGING DIRECToR
C.S.{ILEESH
DIRECTOR
ilr# t
trIemb No: 20lll3 DIN:02941565 DIN:03168499
FR tr"o. 0061865
Place : \'isakhlpatoam
Dare : ()5-09,1022

\,,DIN : 212O I+ lTBBAl JL I LLL

 Chalasani Hospitals Ptivate Limited
50-53- l,l, Gurrds,ara Lane, Seethammadhara, \risakhapatnarn , 530013
(Rupees in lakhs)
STATEMENT OF PROFIT AND LOSS FOR THE YEAR ENDED 3f MAR c}I,2022
Yeat eoded Year ended
Particulars Note No
3lstllr{'arch?f22 31et March 2021

I. Revenue from operatroos 't6 7233.00 6818.87

IL Other Incomc 1',7 46.13 95.65

III. Total Income (I +I| 12',79.13 6914.52

IV. Expenses
Purchase of Stock ro Trade 1444.22 1049.29
Changes ia lnventories of Stock itr Trade 19 -12.33
Employee Beoefit Expenses 20 1456.21 1082.52
Finance Costs 21 617.38 716.23
Depreciation and amortization expenses 9 407.64 465.09
Other Expenses 22 2831.72 3527.12

V. Total ExpenscB 6144.90 6831 .67

\rl. Profir Bcfore Tax (lll - 9 534.22 76.85

YIL Tax Expcosc

Currcnt tax 0.00 0.00
I)eferred'fas '145.41 4'7.28

\-III. Profrt/(-oss) for the year ['l,VI! 388.81 29.51

IX. Earniog pcr eguiry share:

(Nomind Value of Share: Rs. 10)
Basic (lo Rupces) 7.82 0.60
Diluted (In Rupees) i.82 0.60
Notes to -{ccou[rts 1to28
The accompanying Nores ale an iotegral part of the Financial Starements

.\s per our Report of eveq date

For R-\O .\ND SHYAtrI
Chartercd -\ccountants For and on behelf of the Board
. /
,1
a- ta
r) I .t" i%
C,\, fu\IL\ KOl'ESW.\R.{ R\O 'UA \ L\KSHNII 1-.Z-
C.SAILEESH J r:. @,-
PARTNER
Nlemb No: 201.133
NL{NAGING DIRECTOR DIRECTOR e6tr
DIN:02944565 DIN:03168499
FR No: 0061865
Place : \'isakhrpatnam
Date : 05-09 2022

-,DiN )2)otrr'l jBBAy TE l1)-L

Chalasani Hospitals Privaae LiEited
50-53 11, (lunrclwrra Lanc, Sccthammadhara, Visakhaparnam - 530013

CASH FLOW STATEMENT FOR THE YEAR ENDED 31st 20n lal-hs
'n
Yeer ended Year ended
Panicularr 318. M^rch 31st March
nu m2t
A. CASH FLOV FROM OPERATING ACTTVITIES
Net Profir Before Tax 534.22 76.85
Non cash ailjusrment to rcconcile pro6t bcfore ta.x to net cash f1()ws
Dcprccilnon /amortization 407.64 465.09
I)rofit on srrlc of Asset 0.00 36.26
Intcrcsr c,rpcnse 617.38 685.99
lntcrcsr lncornc -17.8r -79.93
Opcratrng l)roht before Working Capital Changes
1521.41 1184.26
IVovcmcnts irr Working Caprtal :
Incrcasc/(dccrcase) in rrade payables
31.54 -691.90
lncrcasc/(dectcase) in othe! cunent Liebilitres
118.25
Dccrczsc/(increase) in long term loans and advances
42.24 -201.11
Dccrcasc/(incrcase) in inveotories -50.51 13.01
I)ccrcese/urrcrersc) rn trrde rcceivables
-706.27 794.76
Dccrcasc/(urcrease) in shon term loans and advaoces -@.12 221.78
Crsh gcncr,rrcJ from/(userl in) operations
6',19.72 ll16.53
Dirccr'laxcs pard Q.,let of MA'l Credit Entitlcmeot) 0.00
Net Cesh flow from/ uscd ln acEutres A 619.72 1136.53
B. CASH FL OW FROM II.IVESTING ACTTYITIES
Purchasc of Fixed r\ssers including Capital Work in progress
-345.95 -258.58
Procccds tiom Sale of l.ixed Assets
0.00 312.80
Intcrcst lncomc 37.81 79.93
Ner Cash flow from/ us in Inves acatuEes -308.14 194.14
C. CASH FLOV FROM FINANCING ASTNTIIES
l,ong'l cr'rl Ilorrowing:; (Ncr) .371.40 235.46
Slrort'l crm Borowings (|.Iet) 268.44 ,300.39
Intercst l)aid -617.38 -685.99
Net Ceeh flow from/ Itl adivities
Net Incrcase / (decreas e) in cash and ceeh cquivelcao (A+B+C)
-726.y
414.75
I@ 579.75
Cash and (i:rsh eqr.rivaleors at the beghning ofthe year
937.n 357.48
(lash and ()sh uivalcnts at the end ofthe !84.16 931.21

ttk
L
 Notcs
l Statcmcnt oi clsh tbw has bccn prcpared uodcr the indircd m(hrxl rrs sct out in .,\s l on ',statcmcnt of Cash
|lows' spccitiul Lrl)Llcr Sccdon 133 ,)f thc (i)mpanics .\ct, 2013 rc:Ltl with ltule i of thc (iompanics (r\ccounrs)
Itulcs.20i.l.
2 Rccrncdiari,,n ,ri (lash and Oash l-qurvalenrs as per the sraremcnr oi ( -;rslr Flows

AB et As at
Panicularr 31et March 31st March
mn mzl
llalance with banks
In currcnt irccount 15.81 550.16

Cash in harrd
5.67 4.93

Other ltank B.rlrrnccs

Margr4 Nloncy Dcposits 363]8 182.14

Cash and cash uivalents as at the end of the 384.7 6 917.23

't'he accompanying Notes arc
an integral pat of the Finaocial Starcmcnts.

I.'or R \O.\Nl) SI IYAM

Chancrcd,\ccounrants For and on bchalf of rhc Board

c {c"
c,\. L\NL\ K( )', is\g,\tu\ ll,\o C,VI KSI INII C,SAILEESIT
P.{R',lNlill i\6NAGING DIRI'C IoII DIRF,C-I'oR
Memb No: 201{33 DIN:02944565 DIN:03168499
IrR No: 0061865
Place : V,sakhAp.ttnam
l)ate : 05-09-2022

UDIN i 2220 r+ 33BBAY JE 111.1

Chalasani Hospitals Pdvate Limited

NOTES:
1. Corporatc lnformation:
The Chrlasani Hospitals Pvt Ltd is a Private Lirnitcd Company incorporated under the Companrcs
Act 195(r. The Company is a sentce entity providing hospital services which .includes full range ,,1
diagnostic and therapeutic medical services-

2. Basis of Prcparation of Financial Statements

The Financial Statements have been prepared under historical cost convention and on accrual rn
accordance wrth Generally Accepted Accounting Pnnoples in Indra (Indran GAAP), Accounting
standards rlotifi.ed under Section 133 of Companies Act, 2013 (the Act) read wrth Rule 7 oi
Companres (Accouns) Ru1es,2014 and relevant provisions of the Comparues Act,2013. lhc
Financial Statements have been prepated as per Schedule III of Compames Act, 2013.

2.1 Summary o I Sigini6cant Accounung PoLicies

a. Property, Plant and Equipment

Property, Plant and Equrpment are stated at cost less deprectation. All costs direcdy attnbutablc rr
bnnging rhe assets to thek working conditions for the intended use are capitalised.

b. Depreciauon:
Depreciation on Property, Plant and Equipment is provided on WDV method at the rares and in rhe
manner prescribed in Schedule II of Comparues Act, 2013.

C Recognitron of Income and Expenditure:

AII Incomc and Expenditure having material bearing on the financtal statements are recogmzed on
Accrual basis.

d. Inventories:
Inventorics are valued at landed cost or net realisablc value whichever is lower.

e. Turnovcr
Tumovcr is stated at Invoice Yalue net of Discounts and Taxes

f Borrowrng Costs attributable to acquisidon, construcrion of Quali$nng asset are capitalised as

l)urr
of the c,rst of that asset till the month in which the asset is ready to use. Other Borrou,ing costs rrc
recognised as Expenses rn the period in which they are incurred.

g. Taxes on Income:
i. curent Year's Tax is detetmined in accordance with the applicable provisions of Income'l.ax ,\ct,
1961. Irlnrmum Altemate Tax eligible for set off in subsequent years is recognised as an asser lrr
way of crcdit ro rhe profit and loss account.

ii. Defcrrccl rax is recognised for the Tax effecr rt present'rax rates on the drfflerence bcn,",ccn
taxablc income and accounting i ncome which are not permane e subject to rhc
considcrarion of prudence principle.

Ph
(lt" o*r-
2536ft
W
t
 ',
Chalasani Hospitals Private Limited

NOTES: s in lakhs
3 Share Capirat As at As at
Slat Nltch ?-022 31st March 2021

4 Authoriscd Share Capital:

5000000 number of Equity shares ofRs. 10 each 500.00 500.00
@Y: 5{l{10000)
b Issued, Subscnbed and Fully Paid up Share Capital:
4969510 number of Equity shares ofRs. 10 each 196.95 196.9s
QY: a969510)
c Par Value per Share Rs 10.00 10.00

d Number of equrty shares at the begioning of the year 49.7 0 ,19.70

Add: Further Issue 0.00 0.0cr
Number o[ equity shares at the end of the year 49.70 49.70

e Terms/Rrghts attached to Equtry Shares

The Company has single class of equrty shares having par value of Rs r0 per share.
Accordingry, a[
equiry shares rank equally wrth regard to dividends and share in the comfany's
.esrduar assetf.'The
equity sharcs are eotidcd to receive dividend declared from time ro time.

f Number of shares held b sbare holders more 570 of total shares

Name of tbe Sbare holder No of Shares No of Shares
Chalasam Vi jayalakshmi 4964410 4964110
% of Holdin 99.90 99.90

c Number of shares held Promoter at the end of the ear

Name of the Promote.r No of Shues No of Shares
Chalasani Vilayalakshmi 49,64,410 49,64,110
7" of Holding 99.90o/o 99.90at
% Chan ed the 0.00% 0.000',1

r PT
ffi4-
21656
Chalasari Hospitals Private Limited
in lakhs

4 Reservct and Surplus As e.3tut March 2022 Ar at 31st Ma.ch 2021

Surplus fronr l)rofit & Loss rccount

()p$ring b,rllrDcc 130.r 5 100.58
,\dd. (|trrLcnt year surplus 388.8r 29.51
Olosing bahnce 5r8.96 130.15

51t.96 130.15

As a( As .t
5 Loog Term Borrowines Jlsr Ma,ch 31et March
2022 2021
'lcrm l,(mrrs

[) Irrom Barrks (Refer Notc) 5550.49 5992.89

(securcrl by cqurrable mortgage of Land, Building"
-j frb.rl,
& Machirrcry and guarantced by the Directon)

b Inans aad ldvaoces froh related pardes 0.00 3.71

(LJnsccurcd)

5550.49 5996.@

Notc:
a) IIDITt) ll,u,k
'lhe Comparry has availcd a Rupee'l'enn Loao of Rs,530000000
from I II)lrC Bank l-td., whicb is repayable in 126 rnonthly
irrsta.llaenls cornmctcing from Nobember 2019 with the intercst payablc beiog linked to HDF(I Bank's brse mrc. 'Ihc
loa,r rs
sccurcd with hrst and cxclusive charge oo stock and book debts ofthc company, connnued chrrge on the l.ixcd t)cpost
oi I(s.
l00laltrs prrrkcd with tlDlr(i bank as securiry ti.ll rhe currency of thc k:rrr ftrciliry and wrth equirablc monagc oo land ru:rl
building.
b) lndus lud li,rnk l,td
'lhc Comprny has availcd a'l crm Loan of Rs. 3,10,00,000 from Indus Ind uank Lrd for purchase of Nfedical cluipmenr wlri(l)
is repayablc rn 30 monthly insm.llncnts commmcing from Novcfrbcr 2019-'[te loan is secured with Medical cquipmclt frr
purchasc which rhc loan has beeo availed.
c) \'cs Bank
'lhe (-ompany has avarled a 'ltrm lran of Rs. 10822514 from Yes tlank l-rd tor purchasc of Medical equipmenr which is
repayablc irr 67 liquated Monthly insallmms commencing ftom April 2018. 'fhe loao is secured wrth Medical equipmcut
foL
purchase which thc loao has bem availcd.
d) Ycs llank

'lhe Compaov has availed a'krm han of fu. 14538667 from Ycs llnrrk l,rd for purchase of Medical
cquipmcnt which is
rcPayablc in 68 l':quatcd N{oothly installrDmts commmcing from
Januarv 2019. The loan is secured vith Medical eqgipmcrrr 1rr
purchasc which rhe loan has beeo availed.

6 Sho( Tcrm Bo
a l.oans tcpayablc on deoand
fnrm banks (llefct Note) 25.38 925.64
(sccured .rgai st thc hypothccedon ofstocks and book dcbts
and guirilDrccd by rhc l)irccroni)

b (lurrcnt i\lrrrrr rncs of Irxg'term Borrowings 681.99 616.29

1E10.37 1541.93

tr_otc
IIt)lr(l Brok
'l hc (Jompanr
has rvadcd a !(torking Oapiral 'l crm Loao o f ll.s. 103800000
from LIDITC Bank l,rd which is rcpayablc in 60
rnorltltlY illslrllrtlcnts commc ci|rg ftom Ircbruary 2022 vi
th intcrcst bcirrg linked to III)lt(l Barkl fltte, Durirrg the vr;rr,
drc (irmpaov has repaid pflncipal amount to thc cxtcnt of
lls. 3677869.'lhc loan is sccurcd roPcrtics ()[ rltr
(irrnpany
,o
.t fi .,t
.t ).rfa. !I {
.
,T " i.r"i' ' ,.'' I
, . :,",/\r-dirp -,,
' Chalasani Hospitals Private Limited
ecs l-r lakhs

Ae at As at
7 Ttade Payables 3lst Match 31st March
mz2 2021
a Due to Micro Small and Medium Enterprises 0.00 0.00
b Due to related parties 41.24
c Others 1562.18 I5l9 63

t@3.42 t57t.E7

Trade Pa bles -\ Schedu.le

Particulars Outstatrding for follou/i ng periods ftom due date of payment
[.ess than 1 TYear - 2 ZYeat - 3 More than 3
Not Duc Year Years Yearc Years Total
(D MSME 0.00 0.00 0.00 0.00 0.00 0.00
(ii) Others 0.00 1346.t9 150.13 82.03 24.47 't603.42
({Disputed Dues - MSME 0.00 0.00 0.00 0.00 0.00 0.00
(iii) Disputed Due s - Others 0.00 0.00 0.00 0.00 0.00 0.1r0
As at Match 31, 2022 0.00 1J46.79 ls0.13 82.03 24.47 1603.42
MSME 0.00 0.00 0.00 0.00 0.00 0.00
(ii) Others 0.00 1203.23 239.31 71.08 58.20 15t 1.8i
(glDisputed Dues - MSME 0.00 0.00 0.00 0.00 0.00 0.00
(!1)Disputcd Dues - Others 0.00 0.00 0.00 0.00 0,00 000
Ae at March 31, 2021 0.00 1203.21 239.37 71.08 58.20 1571.E7

8 Other Cunent Uabilitieg

a Othcr Payables
Sratutory Payablcs 194.34 191.--l
Advance from Customers 15.26 23.O1

m9.@ 274.80

6h'
Ph
m{-
m5fu
Chalasani Flospitals Privare Limired

Gross Block Depreciation Net Block

2 Property-Plant & Equipment As at As ar
Opeoing Op.oi"g 31st March 3lsr March
bal,ancc Additions Deletions Toral beleace Additions Deletione Total m2, m21
Land u.2a 14.28 14 28 t!?8
b Building; 1224.68 t1qL66
3228.68 !!q.60 1114.4 1482.41 1641.01
c Compurers 73.08 11.54 44.62 65.16 7.99 73.55 11.27 7'72
d Elecuical Finings & Equipment 117.4 716 124.64 95.65 6.U 102_4_ 22 34 21 93
9 Furniture & FL\rLues 218.16 & 99 227.55 191 11 7.43 i28 24 28;ll 27 46
t Nledical Eguipment (Others) 1772.14 2lr 79 198!.94 tngr,rl 107.51 1407.11
q I\Iedical E<lLripmenr (Lif; Sa;ng) I7!1tr !2:4a.
2228.87 _91 58 2311.44 1815.35 94.71 1914.05 399.39 413.52
h Ge,neral Plant and Equipment 345.67 9.31 354.98 249.93 16.11 306.05 48.93
\/ehicles !1,1a
'total
el,qg 6.11 101.91 8q.12 ,71 91.16 10.75 141
8094.56 339.48 0.00 84!4.M 5433.11 40;i71 0.00 5839.28 259475 266t.4s
1ll Intangible Asset
a Hospiral Software 26.10 6.48 32.58 24.96 7.47 26.43 6.15 1 1+
Toral 26.10 6.48 o.o0 32 58 24 96 1.47 000 26.43 6.15 114
Grand Total 8120.66 345.95 0.00 8466.62 5458.0',7 fi1.64 0.00 5865.11 2600.90 2662.59
8488.87 96.61 464.42 8120.66 5048.74 465.(9 55.77 5458.07 2662 59 344{t 13

#
Chalasani Hospitals Private Limited

tl ces in llklrs
As at As at
10 Capital Work in Progress 3lst March 3lst March
2022 2027
L Capital Work rn Progtess
Construcdon of New Chambet for Doctors 268.71 I 31 .{X)
Development of FAP and Clinicvantage Accounting Sofrware 30.98 l0 9rJ

299.69 161.97

Ca tal Work in Pro Ageing Schedule

Amount in CWIP for a of
Particulars Less than 1 lYear -2 2Year - 3 More than 3 Total
Year Years Yeats Years
Pro ects in Progress 737 _71 131.00 0.00 0.00 268.7 t
Projects Temporanly Suspended 0.00 30.98 0.00 000 30 9lJ
As_ at March 31, 2022 1i7.71 161.97 0.00 0.00 299.69
Projects in Progress 161.97 0.00 0.00 0.00 0.()()
Ptojects Temporarily Suspended 0.00 0.00 0.00 0.00 0.00
As at Match 31,2021 161.97 0.00 0.00 0.00 161.97

& Ph
ff4:
2G60ts
Chalasani Hospi tals Private Limited
es io Iakhs
1t Non-current Investments As at As at
Slet Match 2022 31st March 2021
a Investment in Equity Instruments
Fullv Paid Equity Shares (unquoted)
Vijavnagar Hospitals Private Limited 318.00 318.00
(318i100 lakh Equity Shares of Rs.100 each)

318.00 318.00
b Book Value o[ Un uoted Investrnents net of rovlslon 318.00 318.00

t2 Term Loans and Advances

a Capital Advances
402.56 362.12
(Jnsecured, considered good)

b Security Deposirs
51.22 49.42
([Jnsecured, considered good)

453.78 411.54

13 Inventories
a (as per Invenrory taken, valued and certr6ed by
Management)
Stores
123.01 84.89
Stock in Trade
107.60 95.27

230.67 180.16

bk
Chalasani Hospitals Private Limited

AE at
t4 Trade rcceivables 31sr March 3lsr March
mn 2021
'l mdc rcccivrblcs
Securcd considcrcd gtxrd
0.00 0u0
Unsccurcd, colsidcrcd good ']Il53
1559.56 tl]
Doubtful
0.00 (_).0(l

4559.56 3E53.29

I'radc Rcccir,rblcs Schedule

Outst [di for fo from duc dttc of eDt
Not Due
For Uabille kee than 6 Moarhe Morc that
Particulare d 6 months -I Yc.r 1.2 Yearr 2-3 Ycars 3 Ycars Toral
(i) Uodisputud 'liade Receivable-
considcrcd x,d 0.00 0.00 Il-:.18 730.99 689.33 625.08 .1559.56

G
74r.68
(ii)Undispurcd I r:rdc l{eceivable -
considcrcd doubrful 0.00 0.00

Iil
0.00 0.00 0.00 0.00 0.00
(rii) DisputcLl'l'r.rdc l{eceivable-
considcrcd x 0.00 0.00 0.00 0.00

C
0.00 0.00 i) 00
Dispurcd't radc ltcceivablc,
(rir)
constdcrcd doubtful 0.00 0.00 0.00 0.00 0. 000 0.1)0
al M.Ich 3 Nt2 0.00 0.00 1172.48 7n.9 689.33 625.08 741.68 4559.56
(i) Undisputcd'l radc llcrceivable-
coosidcrcd

ITC
0.00 0.00 1385.00 391.18 1153.42 511.60 411.48 3853:9
(irJUodisputcd 'l radc ltcceivablc -
considcrcd doubtfr.rl 0.00 0.00 0.00 0.00 0.00 0.00
(iii) Disputcd 'l Ladc Rcceivablc,
considcrcd 0.00 0.00 0.00 0.00 0.00 0.00

G
0.00 0.00
(iii) Dispurcd'L r.rdc Recervable,
considcrcd doubrful 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Ae at March 31 2021 0.00 rililn 138s.00 391.78 ll5.!.n 511.60 411.,l8 1853.29

&
Chalasani Hospitals Private Limited
es in lakhs

15 Cash aod Bank Balances As at As at

31st March 2022 3lst March 2021
a Cash and Cash Equtvalents
i Balancc rvith banks
In current account 15.81 550.16

ri Cash m hand
5.67 4.93

b Other Bank Balances:

Margn \{oney Deposits 363.28 382.14

384.76 937.23

16 Short-term loans and advances

L Advances recoverable in cash ot kind
220.22 186.79
(unsecuted, considered good)

b Balance rvith Revenue Authorities

730.52 704.54
(unsecured, consideted good)

C Employee Related Advances

6.41 s.50
(unsecured, considered good)

957.16 896.84

&
Chalasani Hospitals private Limited
in lakhs
Year ended Year eoded
IJ Revenue from operatiooe
3lst March 31st March
2022 2021
A Sale oi Services
i) lrlechcine Sales
2062.86 17 46.29

ii) I{osprtal Collections

5170.',L4 5072.58

7233.00 6818.E7

18 Other Income
a Ioterest Income
37.81 79.91

b Other non operaung income

8.31 15.72

46.1i 95.65

19c es in Iaventotiee of Stock ia tradc

Invenro5 at the eod of the yea_c
l)lu!rnacy Stock
107.60 95.27
'foral
107.60 95.27
B Inventory at rhe begroning of the year
Pharmacy Stock
95.27 92.70
Total
95.27 92.,- 0
C s rn Ioventories ofStock irt trade
-12.33 -2.57

&
 Chalasani Hospitals private Umited

in lalhs
s
20 Salades & Wages Year ended Year ended
3lst Matcb, 2022 31st Match 2021
a Salaries & \\,ages
1362.22 1.011.27
b Contributron to Provident & Other Funds
18.03 26.61
c Staff Welfhre Expenses
76.02 44.64

7456.27 7082.52

21 Finance Costs
a Interest Expenses
616.72 68s.99
b Other Borrowing Coscs
0.66 30.24

617.38 776.23

22 Other Ex nsea
a Aarogyasri Expeuses
8.19 3.90
b Advcrtisemeqt
35.14 36.17
c Audit Fees
as Starutory Auditor
4.00 4.00
for Taxauon Mafters
1.00 1.00
d Bao.k Charges
24.57 25.46
e Consultation Charges
1460.86
f Conveyance Expenses 1,103.58
2.73 2.51
Diagnostic & Lab Expenses
157.06 144.38
h Disa.llowances ftom Bills
0.00 683.95
Donations
0.00 1.69
t Hospital Ir{aintenaoce
607.40 546.78
k Insurance
8.56 6.84
Loss on Sale ofAsset
0.00 36.26
m Medical Gases
133.21 0.00
n Power & Fuel
164.54 156,21
o Postage & Couner
4.05 4.21
P PrinUng & Srauoncry
31.37 26.58
q Rates and Taxes
38.02 49.05
I Rent
38.84 33.82
s Repairs & N{aiotenance
33.24 290.51
t Security Scwrces
57.51 50.59
u ltlephone Charges
12.38 'r0.21
Traveling Expenses
3.56 2.65
w Transportation Charges
x Vehicle Repats & Maintenance
l.9t 0.00
2.21 3.86
v Other Miscellaneous Expeoses
1.36 2.89

283172 3527.12

&
Ph
61-
2fuofu t
Chalasani Hospitals private Limited

l(D

21 4.6 at As er
3l6t ][,,rtch 2022 31st March 2021
Coa ting€nt liabiliries & Commitrnetrts
1306030 Nil
(to thc exrcnd n(,r proyided for)

b Value oflmporas oo CIF baeie mede

Nit Nil
c Expc[se6 i[currcd i[ Foreig[ CurreEcy Nil Nil
d Amount remined in Foreigr cxctange
Nil Nil
c Earaiage in Forcign Exchaagc
Nit Nil

4
1. Key lleoagenal l,crsonoel:
I)r. C.\Triayalakshmi
I)r. C.Sailccsh

2 Relarives of llel.rtcd parties:

Dr. C.Usha

3. l)oterprises in rvhich Key M.nagerneot peBonnel

and / or their Rclarivcs have sigruficant influence
Chalasani Bio l,hrrma pvt.l,td.
Vijayrnagar I Iospitals prt Ltd.

te Relarerl l)a &aosactions

s in lakhs
Enterprises in which
Key lt{anagement
Personncl and / or
Key Managcmcnt Ilclativcs of rheir Relatives have
Particulars
Personnel llclarcd Parries
Ttansachoos ficant influence
for rhe ycar eoded 1l _03.2022
1. Professional (ih.rrgrs (As oo 31.03.2022)
53.00 15.00
(.\s on 11.03.2021)
24.50 8.75

2. Purchasc O[trlcclicines (,\s on 3l.03.2022)

399.56
[\s on 31.03.2021)
262.15
Balanco as on J 1.0J.2022
1. Trade & Othcr l)avables (As on 31.03.2022)
(\s 13.85 41.24
on 31.03.2021)
3.93 1r.63
2. Unsccr.rrctJ l_,r:rr:s l,\s on 31.03.2022)
000
(,\s orr 31.03 3011)
3.,11

3. Non (lurrcor Lrvcsrmenrs (r\s

o,r j1.03.2022)
(-\s on 31.03 3{J2l) 318.00
318.00
{. (irprral ,\dvarr.rs ( \s on 31.03.2022)
320.00
-(.\s on I LUI t()t I r

320.00

4. Sccuriry l)cposits (.\s oo

31.03.2022)
\s oo 31.03.2021 9.26
9.26

;\
N \I
Ph
@1-
,i
2$5# I
,i ,th
25
liu ccs in lakhs
Yea, ended Ycar ended
Dcfcrrcd Tex Asset 3lst Much 2022 3le. Ma.ch 2021
Timing ditri rcolc rn rccogflition {)t Iixpendhrre
I)eprccrarion
lr 1.98 .169.80
13.29 60 89

385.27 530.69
Defa..cd Tax Asser
185.27 530.69
26 'rhere is n, Impairmcnt ofr\sscts as rhe carrying cost ofassets does not cxceed
the recoverabre amounr

k .1
001-
2036fu
Ph

I
Chalasani Hospitalo private Limited

Notc No 2?
Additiond regularory infotmatioa
(i) R.tio3

Paniculars Nulr€aatoa D€norninator A.s at As at Variance

31st March 3lst Ma.ch
(-urrcnt rario 20?2 2021
(lurent assets Cutrenr liabilihes
1.69 1.76
@)Debt-cqutv ratio Borrowings( Non Net Wolth -4.070/0
(lutent + Cu rrent) 7.25 12.02 39.130/r
(c)Dcbt scrvrct liarungs arailable Debt service
covemgr ratio 1.6r 18.89
for debt service
91.190k
(d)Retr.rm on cauiry N et profit a fter taxes Average Shareholders
ntso 0.77 0.09
Eq"i y 111.620/0
(e) [nvc'l]ton Cost of goods sold Average ioventory
6.97 5.61
24.31,vo
(f)Tradc rcccilablcs otrl Sales verige trade receivablcs

1.12 1.60 7.190k

(g)'Indc payablcs 'lbta.l I\chases ,tverage trade payabies
1.06 0
71.15V.
(r)Net capiral Revenue from (lurren t Assets-(:urrent
tumovcr ratio ()perations 2.88 2.69
Iiabilides 7.350/o
(i)Ner profit r,ft) Net p!o6t afrer Bxes Reverr ue from opemrion-s
5.38% 0.43yo
1139.550/"
flReturn ou cupir liamhgs before 1b el Asseh- Curreot 1r.090/0 9.34%
interest and taxes li2bilines 40.11%
ft)Re tr.rm on Income from Avenge Co st ofinvestmcnt
invcshcDt investrnenN

lleesons for chan b more than 250%

Paniculac
Reasoo
aurabl Change llctease fl equrty d t( ln
l)ebr I{atro to re ductio n rn deb PTO fi ts when P ared to as l/ear ca d
tu reEo
Debt Servicc Ft vourable C ha n8e. Rc duc tson ln Overall
C Ratio
Dc l, f rh Co mPa nv aJong h rn Pfo firs
ead reduc rn de b r,
Rctt:m ou Iicluity
Raao I ievor.uable ( due to increase in rofit when com
Tnde Payablcs to car
tumover mtl() Favourable Ch AO due to increase in fir which led to cteditor ofl cune
Net Profit R rio lravourable Ch due to increase tr 6t whc.a
Retun oo captt:rl ro

lo cd Iavourable C ha due to inccase in 6t whco to

*
Ph
6{-
?t3508 I
 (b) Additional Disclosures

as required r.rndet schedule III to the act to rhe exrent appticabte to

1"1"T#:ffn:Msclosutes the

propertv, where .rnv proceeding has been

3"il:,.1:X"r:.*i:"li J.:"Xl.fi:ami initiated or pending against thc

jf).]e Cor.lrny aoe, not hare aoy t arrsacrions u,ich companies struck off.
not.have aov charges or satisfaction which
is vet to be regrstered onth Regrsrrat
ttiJi;:Tlil,H ; of companicr
(iv) The company has not rraded or invesred in
cr,?to currency ot virt.ar currency during the
year ended xlarch 31 ,

(v) The Company has not advanced

or loaned or invested funds ro any orler oe^onrs\ 6r p6;n,/;-.1
entitres 6r,,ter,nediati.r) *;;;;.*,^ding *t'on(s) ot entity(ies), rncludrng foreign
that the Interm"*"r, ,o*ltt
(a) directly or rnduectlv lend or
invest ino,h..;rr."r ro any maoner whatsoever by or on
of the company (Jlti.tnate Bene6ciades) or ";.;;;;;;"0';.d be'arf
O) plovrde anv guareotee, security or the [ke to or on
behalf of r]re Ultimate Bene6ciaries.
(vi) The Company ha" not recerrred a'y
fr-d fr.. -y p"r;;.i;; ., _.rrding foreign enuties (Funding
wuh th: understanding (utether recorded ""rfr,'[*;,
lY.)
(a) &ecdy or ind'ectly lend or invest
in writing or otlr".*r.) L"t tfr. Compaay shall:
o,h., p.rron, or loo* ,;;l;; ,, *y *"r-er v,hatsoevet by or on behalf
^
of the Fundrng party (Ultimate Bencficiatie$
oi
,r,S*-"ree, security or the like on beha.lf of the Ultimate
!),n1vraa. Beoe6ciaries.
(uil r ne LornPany has no such transaction
which is not recorded in the books of
acco,nts that has been surrendercd
'or disclosed as income during the yeat in the tax assessmmts una", ua I*"-.
sun'ey or any orher televanr provisions of
r* act, 1g61 (s'ch
as, search or
the Income Tax .{ct, I ?61).
(u,,J Ihe borror*mg ftom Enancia'l instirutions have
been used fo. r]re purposes fot which rt
was raken at the barrrrce
(ix) AJI title deeds of the imrnovable r ery (other than the properties u,hete the compaay is the
il ;;;;f;;. ; lessee) are hetd in
(x) Thc company has complied with
thc number oflayers prescribed undet
with Companies @estdcdon oq nuober oflayers;
clause (gf of sectioa 2 of the .\cr read
Rules, iOt 7 .

Las not prepared any S.h.-. of Aoar,g.*ents in tetms of sections 230

,,7 of rhe Companies
fL$;{"rn^r to
(xi) Corporate Social Respoosibiliry is not applicable
to thc Comapny.

Note No 28
Previous vear figures have beeo regrouped
wherever necessary to cooform with
cureot year classificatron.
.{s per our Report ofeven date
For RAO .{ND SFIyAN{
Chartered .\ccountants
For arrd on behalf of the Board
, - / /-
ffn-'-M^"fi,- C -,-'-'_ I
CA. RANfr\ KOTESVflAXA RAO
C. Y L\KSHM] C.SA]LEESH
P,\RTNER
MANAGING DIRECTOR DIRECTOR
Nlemb No: 201433
DIN:02944565
FR No: 0061865 DIN:03168499
Place : \'isakhapatoam
Date :05-09-2022